Join Now

EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

By Press Release | Published May 16, 2024

Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases

Posted in BioUtah News | Tagged | Comments Off on EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

A Special Thanks To Our Elite Members